Then we performed survival analysis in TCGA database and found that FAISL was not significantly associated with the overall survival and disease‐free survival (DFS) in the breast cancer cohort (Figure S1H,I, Supporting Information). This evidence concerns the gene VPS9D1-AS1 and breast carcinoma.